Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating hormone concentration (HP:0003117)help
Parent Node:
expand
Abnormal circulating adrenocorticotropin concentration (HP:0011043)help
..Starting node
..expand
Decreased circulating ACTH level (HP:0002920)help
Term ID: 2920
Name: Decreased circulating ACTH level
Synonym:
Definition: An abnormal reduction in the concentration of corticotropin, also known as adrenocorticotropic hormone (ACTH), in the blood.
Comments:
Reference: HP:0002920
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandIncreased circulating ACTH level (HP:0003154) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002920HP:0002920Decreased circulating ACTH level0AIP CL E G H9049358ORPHA:2965ProlactinomaHP:0040282 - Frequent95
HP:0002920HP:0002920Decreased circulating ACTH level0AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0002920HP:0002920Decreased circulating ACTH level0ARMC5 CL E G H7979825781OMIM:615954ACTH-independent macronodular adrenal hyperplasia 27
HP:0002920HP:0002920Decreased circulating ACTH level0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0002920HP:0002920Decreased circulating ACTH level0BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0002920HP:0002920Decreased circulating ACTH level0CDH23 CL E G H6407213733ORPHA:2965ProlactinomaHP:0040282 - Frequent636
HP:0002920HP:0002920Decreased circulating ACTH level0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040282 - Frequent636
HP:0002920HP:0002920Decreased circulating ACTH level0FOXA2 CL E G H31705022ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent
HP:0002920HP:0002920Decreased circulating ACTH level0GLI2 CL E G H27364318ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent173
HP:0002920HP:0002920Decreased circulating ACTH level0GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0002920HP:0002920Decreased circulating ACTH level0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0002920HP:0002920Decreased circulating ACTH level0HESX1 CL E G H88204877ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent21
HP:0002920HP:0002920Decreased circulating ACTH level0HESX1 CL E G H88204877ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional21
HP:0002920HP:0002920Decreased circulating ACTH level0LHX3 CL E G H80226595ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional51
HP:0002920HP:0002920Decreased circulating ACTH level0LHX4 CL E G H8988421734ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent43
HP:0002920HP:0002920Decreased circulating ACTH level0LHX4 CL E G H8988421734ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional43
HP:0002920HP:0002920Decreased circulating ACTH level0MEN1 CL E G H42217010ORPHA:2965ProlactinomaHP:0040282 - Frequent462
HP:0002920HP:0002920Decreased circulating ACTH level0NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0002920HP:0002920Decreased circulating ACTH level0NFKB2 CL E G H47917795ORPHA:293978Deficiency in anterior pituitary function-variable immunodeficiency syndromeHP:0040281 - Very frequent11
HP:0002920HP:0002920Decreased circulating ACTH level0OTX2 CL E G H50158522ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent41
HP:0002920HP:0002920Decreased circulating ACTH level0OTX2 CL E G H50158522OMIM:613986Pituitary hormone deficiency, combined, 641
HP:0002920HP:0002920Decreased circulating ACTH level0PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0002920HP:0002920Decreased circulating ACTH level0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0002920HP:0002920Decreased circulating ACTH level0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0002920HP:0002920Decreased circulating ACTH level0PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0002920HP:0002920Decreased circulating ACTH level0PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0002920HP:0002920Decreased circulating ACTH level0POU1F1 CL E G H54499210ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent36
HP:0002920HP:0002920Decreased circulating ACTH level0POU1F1 CL E G H54499210ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional36
HP:0002920HP:0002920Decreased circulating ACTH level0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0002920HP:0002920Decreased circulating ACTH level0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0002920HP:0002920Decreased circulating ACTH level0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0002920HP:0002920Decreased circulating ACTH level0PROP1 CL E G H56269455ORPHA:95494Combined pituitary hormone deficiencies, genetic formsHP:0040282 - Frequent54
HP:0002920HP:0002920Decreased circulating ACTH level0PROP1 CL E G H56269455ORPHA:226307Hypothyroidism due to deficient transcription factors involved in pituitary development or functionHP:0040283 - Occasional54
HP:0002920HP:0002920Decreased circulating ACTH level0PROP1 CL E G H56269455ORPHA:90695Non-acquired panhypopituitarismHP:0040282 - Frequent54
HP:0002920HP:0002920Decreased circulating ACTH level0SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0002920HP:0002920Decreased circulating ACTH level0SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0002920HP:0002920Decreased circulating ACTH level0SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0002920HP:0002920Decreased circulating ACTH level0SOX3 CL E G H665811199ORPHA:90695Non-acquired panhypopituitarismHP:0040282 - Frequent24
HP:0002920HP:0002920Decreased circulating ACTH level0SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0002920HP:0002920Decreased circulating ACTH level0TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0002920HP:0002920Decreased circulating ACTH level0TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent


Genes (30) :AIP AKT1 ARMC5 BAP1 CDH23 FOXA2 GLI2 GNAS HESX1 LHX3 LHX4 MEN1 NF2 NFKB2 OTX2 PDE11A PDE8B PDGFB PIK3CA POU1F1 PRKACA PRKAR1A PROP1 SMARCB1 SMARCE1 SMO SOX3 SUFU TERT TRAF7

Diseases (14) :ORPHA:2965 ORPHA:2495 OMIM:615954 ORPHA:189427 ORPHA:91347 ORPHA:95494 OMIM:219080 ORPHA:226307 ORPHA:293978 OMIM:613986 OMIM:610475 ORPHA:189439 OMIM:610489 ORPHA:90695
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.